111 related articles for article (PubMed ID: 17587577)
1. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid.
Dixon MJ; Bourré L; MacRobert AJ; Eggleston IM
Bioorg Med Chem Lett; 2007 Aug; 17(16):4518-22. PubMed ID: 17587577
[TBL] [Abstract][Full Text] [Related]
2. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
4. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
6. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization.
Giuntini F; Bourré L; MacRobert AJ; Wilson M; Eggleston IM
J Med Chem; 2009 Jul; 52(13):4026-37. PubMed ID: 19492812
[TBL] [Abstract][Full Text] [Related]
7. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
8. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
9. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy.
Di Venosa G; Vallecorsa P; Giuntini F; Mamone L; Batlle A; Vanzuli S; Juarranz A; MacRobert AJ; Eggleston IM; Casas A
Mol Cancer Ther; 2015 Feb; 14(2):440-51. PubMed ID: 25519699
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
11. Design and Proof of Programmed 5-Aminolevulinic Acid Prodrug Nanocarriers for Targeted Photodynamic Cancer Therapy.
Wu J; Han H; Jin Q; Li Z; Li H; Ji J
ACS Appl Mater Interfaces; 2017 May; 9(17):14596-14605. PubMed ID: 28397487
[TBL] [Abstract][Full Text] [Related]
12. Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Br J Cancer; 2009 Mar; 100(5):723-31. PubMed ID: 19240715
[TBL] [Abstract][Full Text] [Related]
13. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
14. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
15. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study.
Battah S; O'Neill S; Edwards C; Balaratnam S; Dobbin P; MacRobert AJ
Int J Biochem Cell Biol; 2006; 38(8):1382-92. PubMed ID: 16546435
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents.
Zhu CF; Battah S; Kong X; Reeder BJ; Hider RC; Zhou T
Bioorg Med Chem Lett; 2015 Feb; 25(3):558-61. PubMed ID: 25556100
[TBL] [Abstract][Full Text] [Related]
18. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.
Rodriguez L; Vallecorsa P; Battah S; Di Venosa G; Calvo G; Mamone L; Sáenz D; Gonzalez MC; Batlle A; MacRobert AJ; Casas A
Photochem Photobiol Sci; 2015 Sep; 14(9):1617-27. PubMed ID: 26066768
[TBL] [Abstract][Full Text] [Related]
19. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
20. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy.
De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV
J Control Release; 2000 Apr; 65(3):359-66. PubMed ID: 10699294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]